The role of UBE3A in the autism and epilepsy-related Dup15q syndrome using patient-derived, CRISPR-corrected neurons
暂无分享,去创建一个
E. Levine | S. Chamberlain | M. Elamin | Tiwanna M. Robinson | Christopher E Stoddard | Dea Gorka | Aurélie Dumarchey | Christopher Cowie | Christopher E. Stoddard | Marwa Elamin | Aurelie Dumarchey | Christopher Cowie | Eric S. Levine
[1] W. V. van IJcken,et al. Molecular and behavioral consequences of Ube3a gene overdosage in mice , 2022, JCI insight.
[2] Stormy J. Chamberlain,et al. Antisense oligonucleotides targeting UBE3A-ATS restore expression of UBE3A by relieving transcriptional interference , 2021, bioRxiv.
[3] Judy E. Bloom,et al. Hyperexcitable Phenotypes in Induced Pluripotent Stem Cell–Derived Neurons From Patients With 15q11-q13 Duplication Syndrome, a Genetic Form of Autism , 2021, Biological Psychiatry.
[4] F. Saitow,et al. Genetic dissection identifies Necdin as a driver gene in a mouse model of paternal 15q duplications , 2021, Nature Communications.
[5] Rujuta B. Wilson,et al. Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials , 2019, American journal of medical genetics. Part A.
[6] J. Bonventre,et al. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells. , 2018, Current protocols in stem cell biology.
[7] Yixue Li,et al. CRISPR/Cas9-mediated targeted chromosome elimination , 2017, Genome Biology.
[8] J. Lerch,et al. Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2‐q13.3 duplication syndrome , 2017, Human molecular genetics.
[9] James N. Hughes,et al. Targeted Deletion of an Entire Chromosome Using CRISPR/Cas9. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] F. Rigo,et al. Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells , 2017, Nature Communications.
[11] Matthew P. Anderson,et al. Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1 , 2017, Nature.
[12] E. Cook,et al. Mortality in isodicentric chromosome 15 syndrome: The role of SUDEP , 2016, Epilepsy & Behavior.
[13] E. Cook,et al. Identification of a distinct developmental and behavioral profile in children with Dup15q syndrome , 2016, Journal of Neurodevelopmental Disorders.
[14] Michael L. Wallace,et al. GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility , 2016, Neuron.
[15] Stormy J. Chamberlain,et al. Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes. , 2015, Pediatric clinics of North America.
[16] A. Beaudet,et al. Towards a therapy for Angelman syndrome by reduction of a long non-coding RNA , 2014, Nature.
[17] E. Thorland,et al. Does parent of origin matter? Methylation studies should be performed on patients with multiple copies of the Prader–Willi/Angelman syndrome critical region , 2014, American journal of medical genetics. Part A.
[18] B. Graveley,et al. Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1 , 2014, Molecular Autism.
[19] S. Spence,et al. A survey of seizures and current treatments in 15q duplication syndrome , 2014, Epilepsia.
[20] S. Auvin,et al. Duplication of the 15q11-q13 region: clinical and genetic study of 30 new cases. , 2014, European journal of medical genetics.
[21] Bo Zhang,et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish , 2013, Nucleic acids research.
[22] M. Genuardi,et al. Clinical and genetic study of a family with a paternally inherited 15q11–q13 duplication , 2013, American journal of medical genetics. Part A.
[23] Sarah L. DeVos,et al. Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA , 2013, Neurotherapeutics.
[24] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[25] E. Pivnick,et al. The Interstitial Duplication 15q11.2-q13 Syndrome Includes Autism, Mild Facial Anomalies and a Characteristic EEG Signature , 2013, Autism research : official journal of the International Society for Autism Research.
[26] Matthew P. Anderson,et al. Increased Gene Dosage of Ube3a Results in Autism Traits and Decreased Glutamate Synaptic Transmission in Mice , 2011, Science Translational Medicine.
[27] S. Chamberlain,et al. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11–q13 , 2010, Neurobiology of Disease.
[28] Daren Low,et al. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation , 2010, European Journal of Human Genetics.
[29] N. C. Schanen,et al. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13 , 2010, Neurobiology of Disease.
[30] Kiyoshi Inoue,et al. Abnormal Behavior in a Chromosome- Engineered Mouse Model for Human 15q11-13 Duplication Seen in Autism , 2009, Cell.
[31] D. Babovic‐Vuksanovic,et al. Characteristics of two cases with dup(15) (q 11.2-q 12): one of maternal and one of paternal origin , 2000, Genetics in Medicine.
[32] P. Howley,et al. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. , 1999, Science.
[33] T. Mohandas,et al. Paternally derived de novo interstitial duplication of proximal 15q in a patient with developmental delay. , 1999, American journal of medical genetics.
[34] M. Tsai,et al. The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.
[35] B. Leventhal,et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. , 1997, American journal of human genetics.